Author:
Mirzaeian Leila,Eivazkhani Farideh,Saber Maryam,Moini Ashraf,Esfandiari Fereshteh,Valojerdi Mojtaba Rezazadeh,Fathi Rouhollah
Abstract
Abstract
Objective (s)
One way to overcome the recurrence of cancer cells following ovarian tissue transplantation is to use decellularized tissues as a scaffold that does not have any cellular components. These cell-free scaffolds can be seeded with different type of stem cells for ovarian restoration.
Materials and methods
OSCs, PMSCs and BMSCs (oogonial, peritoneal and bone marrow mesenchymal stem cells, respectively) were seeded into human decellularized ovarian tissue as 4 groups: Scaffold + OSCs (SO), Scaffold + OSC + PMSCs (SOP), Scaffold + OSC + BMSCs (SOB) and Scaffold + OSC + PMSCs + BMSCs (SOPB). The produced grafts were transplanted into the sub-peritoneal space of ovariectomized NMRI mice as artificial ovary (AO). The expression of Vegf, CD34, Gdf9, Zp3, Ddx4, Amh and Lhr genes in AOs were measured by qRT-PCR. Also, histotechniques were considered to detect the anti GFP, PCNA, VEGF, GDF9, ZP3 and AMH proteins.
Results
H & E staining showed follicle-like structures in all groups; the number of these structures, in the SOP and SOB groups, were the highest. In SO group, differentiation ability to oocyte and granulosa cells was observed. Endothelial, oocyte, germ, and granulosa cell-like cells were specially seen in SOP and angiogenesis capability was more in SOB group. However, angiogenesis ability and differentiation to theca cell-like cells were more often in SOPB group. While none of the groups showed a significant difference in AMH level, estradiol levels were significantly higher in SOPB group.
Conclusion
Integration of OSCs + PMSCs and those OSCs + BMSCs were more conducive to oogenesis.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Oncology
Reference41 articles.
1. Donnez J, Martinez-Madrid B, Jadoul P, Van Langendonckt A, Demylle D, Dolmans M-M. Ovarian tissue cryopreservation and transplantation: a review. Hum Reprod Update. 2006;125:519–35.
2. Donnez J, Dolmans M-M. Ovarian cortex transplantation: 60 reported live births brings the success and worldwide expansion of the technique towards routine clinical practice. J Assist Reprod Genet. 2015;328:1167–70.
3. Mirzaeian L, Rafipour H, Hashemi S, Zabihzadeh S, Amanpour S. Cryopreservation options to preserve fertility in female cancer patients: available clinical practice and investigational strategies from the Oncology guidelines point of view. Basic and Clinical Cancer Research. 2020;121:42–53.
4. Amorim CA, Shikanov A. The artificial ovary: current status and future perspectives. Future Oncol. 2016;1219:2323–32.
5. Dolmans M-M. From isolated follicles to the artificial ovary: why and how? Curr Opin Endocr Metab Res. 2021;18:62–8.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献